International Society for Pharmacoeconomics and Outcomes Research ( ISPOR )

ISPOR

International Society for Pharmacoeconomics and Ou...'s picture

The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) promotes the science of pharmacoeconomics (health economics) and outcomes research (the scientific discipline that evaluates the effect of health care interventions on patient well-being including clinical, economic, and patient-centered outcomes) and facilitates the translation of this research into useful information for health care decision makers to increase the efficiency, effectiveness, and fairness of health care to improve health. Founded in 1995, ISPOR is a non-profit 501(c)(3) public organization for educational and scientific purposes, as defined by the US IRS, and a non-profit research organization under the European Commission 7th Framework Programme.

ISPOR press release, blog etc

07/09/2018 - 10:35 ISPOR Wins 2018 Power of A Award for Its Good Practices for Outcomes Research Reports
06/28/2018 - 18:39 Value in Health Impact Demonstrates 5th Consecutive Year of Double-Digit Growth
06/28/2018 - 17:21 , the Societys flagship journal, has increased to 5.494 based on new data released by
06/25/2018 - 19:58 ISPOR Announces New Summit on Value Assessment
06/24/2018 - 21:23 Conference Theme and Plenary Speakers Announced for ISPOR Asia Pacific 2018
06/19/2018 - 14:48 Novel Approach to Assessing US Outpatient Drug Costs for Use in Cost-Effectiveness Analyses
06/19/2018 - 14:17 A Framework for the Use of Wearable Medical Devices in Regulatory Clinical Trials
06/04/2018 - 23:52 ISPOR Announces 2018-2019 Board of Directors
06/04/2018 - 11:19 ISPOR 2018 Drew Nearly 4000 Stakeholders in Health Economics and Outcomes Research
05/29/2018 - 09:39 , the professional society for health economics and outcomes research, announced the Best Podium and Poster Research Presentation awardees for its
05/29/2018 - 08:52 Best Podium and Poster Presentations Awarded at ISPOR 2018
05/23/2018 - 14:45 Artificial Intelligence: Is It the Next Big Thing in Healthcare?
05/23/2018 - 13:45 Strengths and Limitations of Patient Preferences to Inform Regulatory Decisions
05/23/2018 - 10:08 How Much Is the United States Actually Spending on Prescription Drugs?
05/22/2018 - 16:23 , the professional society for health economics and outcomes research, recognized honorees of the ISPOR Awards Program at its
05/22/2018 - 15:49 ISPOR Panel Discusses Recommendations and Rationale of Making Medicines Affordable: A National Imperative
05/22/2018 - 15:43 Addressing Challenges of Value Assessment in Healthcare
05/22/2018 - 15:12 Digital HealthHelp or Hype?